A polypeptide-based (‘bioPROTAC’) technology designed to degrade the MYC oncoprotein inside cells, applicable in cancer treatment and prevention
Technology Sectors & Industries
Pharmaceuticals
Filter
citrOgen – the first universal presentation platform for bacterial antigens
A platform for rapidly generating antibodies against diverse bacterial targets, applicable to monoclonal antibody development and the expedited evaluation of potential vaccine antigens
Microbial Peptides for the Therapeutic Modulation of the Human Gut-Brain Axis
Utilising peptides derived from healthy human gut microbiome, this technology offers potential therapeutic applications in treating disorders related to mood, behaviour, and gastrointestinal function by modulating the gut-brain axis.
Dr Andre Brown
Dr David Riglar
Ryhan Miah
Ryhan is a Junior Officer for Commercialisation at Imperial’s Faculty of Natural Sciences.
Long-lasting nanoparticles for controlled release drug delivery
A nanoparticle drug platform that can deliver small molecule drugs over a sustained period in a stable, low-toxic manner.
Dr Nazila Kamaly
Use of Capsaicin/TRPV1 agonists for prevention of diabetic foot ulcers
Topical use of Capsaicin or TRPV 1 agonists for the prevention of diabetic ulcers in a patient suffering from diabetic peripheral neuropathy (DPN).
Diana Yin
Diana supports and leads on the commercialisation of MedTech, and HealthTech related technologies from Imperial’s Faculty of Engineering
Sign up for updates
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean nec venenatis arcu. In fermentum non tellus nec vulputate. Integer accumsan, nunc sit amet porta commodo, diam sapien feugiat purus, at imperdiet arcu nisi quis dui. Etiam vel nisl sem. Proin felis nisl, fringilla eu eros ac, sodales pellentesque sem.